Abstract Details
|
Lakshanya Rajaganapathi
PRESENTER |
Miss Rajaganapathi has nothing to disclose. |
| Vijayalakshmi Rajasekaran, MD, FAAN (University of Pittsburgh) | The institution of Dr. Rajasekaran has received research support from UCB Pharmaceutical drug trail . The institution of Dr. Rajasekaran has received research support from Xenon and Biohaven. Dr. Rajasekaran has received personal compensation in the range of $0-$499 for serving as a Consultant with NaoX. |
| Michael Whalen, MHA | Mr. Whalen has nothing to disclose. |
| Kimberly Murin | Kimberly Murin has nothing to disclose. |
| Alexandra Urban, MD, FAAN (University of Pittsburgh School of Medicine) | Dr. Urban has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuropace. Dr. Urban has received personal compensation in the range of $0-$499 for serving as a Consultant for LivaNova. |